JULIA TURNEY: Open Payments
NPI 1467170399 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 25 payments from 17 companies in 2025. Trend: 2023 $618 · 2024 $20 · 2025 $716
Food & beverage: $617Education: $99
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 2 | $126 |
| Regeneron Healthcare Solutions, Inc. | 2 | $73 |
| ABBVIE INC. | 2 | $54 |
| Eisai Inc. | 2 | $54 |
| Genentech USA, Inc. | 2 | $53 |
| PFIZER INC. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Amgen Inc. | 1 | $28 |
Products named: LYNOZYFIC, Lenvima, Itovebi, Nubeqa, Padcev, FRUZAQLA, IMBRUVICA, IMDELLTRA (AMG757).
Industry payments across VA — which companies pay providers there.
